Latest TGA News

What to know if you’ve been prescribed medicinal cannabis
Do your patients know the risks of unapproved medicinal cannabis products?
Landmark approval of Tzield in Australia ushers in a new era of delay for type 1 diabetes
Updates to Authorised Prescriber (AP) scheme requirements when accessing MDMA and psilocybine
Health practitioners – how to access medicines during a national shortage
Individual issued 27 infringement notices for allegedly supplying Melanotan II
Lapse of provisional registration for Andexxa (andexanet alfa) used for Factor Xa inhibitor (apixaban/rivaroxaban) reversal
Updates To Prescribing Medicines In Pregnancy Database 19 May
Unlawful Therapeutic Goods Seized In Global Operation
Forging an integrative health research alliance with India
Tranexamic acid: risk of serious adverse events after inadvertent spinal administration
New TGA guidance clarifies requirements for compounded medicines
Indonesia: New halal certification requirements for medicines and medical devices
Higher-strength medicinal cannabis may be linked to a disturbing pattern of side effects, our study shows
Efficacy Of Listed Medicines For Exercise Performance
Can’t get your HRT patches? What to do and what to avoid
Updates to the List of Australian Manufacturers Licensed by the TGA
New research raises concerns about safety of higher-THC medicinal cannabis products in Australia
NSW And ACT Target For Illicit Tobacco Strike
TGA issues infringement notices for alleged unlawful advertising of therapeutic goods involving prohibited representations
Veganic SKN directed to cease supply and relabel or destroy unapproved sunscreens
Enforceable Direction: Veganic SKN Limited
AFP confiscates more than $1 million linked to illicit vape sales
Inclusive assessments allow more Canberrans to donate blood
Over 30,000 illegal vaping goods seized in major TGA operation in south-west Sydney
Three Victorians arrested following seizure of over $2 million worth of steroids and peptides by the ABF and TGA
Consumer patient information materials for implantable devices
Therapeutic goods are not affected by the Industrial Chemicals Environmental Management Standard (IChEMS)
Can medicinal cannabis help kids’ autism, ADHD or Tourette’s? Here’s what we know so far
As the Iran war disrupts supplies, will it affect access to medicines?
Will medicinal cannabis help my mental health? Here are the evidence and the risks
Listed Medicine Compliance Reports – March 2026 Update
Speech From Minister Butler, AFR Healthcare Summit
The TGA wants to overhaul sunscreen labels. Will scrapping SPFs work?
Earlier, Faster, And Fairer Access To New Medicines
TGA issues infringement notices to 3 health practitioners for alleged unlawful importation of therapeutic goods
Improving Regulation Of Sunscreens In Australia
Medicinal cannabis has gone mainstream. But Australia’s struggling to cope
TGA Product Information Safety Updates 23 March
Federal government prescribing trial fails to put quality women’s healthcare first
Women’s health is not a pilot project”: RACGP on Government decision to prioritise political donations over safety
National Disruption Group nets millions with major multi-state success
TGA ignored as Victorian Government ‘shortcut’ puts women at risk: RACGP
Peptides And Social Media
GMP Annex 6 and Annex 15 concept papers – Open for public consultation
Update To Listed Medicine Ingredients In March 2026
Ultomiris® now available on the PBS for Australians living with generalised myasthenia gravis
TGA Product Information Safety Updates 25 February